The global photon counting computed tomography (PCCT) market is set to witness a CAGR of ~20% in the next 5 years. Superior image quality and resolution, radiation dose reduction aided by PCCT, rising burden of chronic diseases, technological advancements and AI integration, and increased research and clinical validation are some of the key factors driving the photon counting CT market.
Photon-counting computed tomography (PCCT) is a novel technology that allows higher spatial resolution as compared to conventional CT techniques resulting in improved spatial resolution, enhanced tissue contrast, and minimized image noise while retaining energy specific information. Compared to conventional CT, it provides similar dose reduction, specific material differentiation, and reduced contrast resolution; making it highly desirable for advanced imaging of diagnostic value in oncology, cardiology, and neurology areas. Overall photon counting CT represents a significant leap in diagnostic imaging technology.
Click here to get our sample PDF report for Medical Devices market:
https://meditechinsights.com/photon-counting-computed-tomography-market/request-sample/
Superior image quality and resolution to drive market growth
The ability to provide superior image quality and resolution is a key factor contributing to the growth of the PCCT market because it will significantly improve diagnostic accuracy. PCCT technology utilizes advanced detectors that count individual X-ray photons and store their energy information. This yields greater spatial resolution and improved contrast-to-noise ratio compared to conventional CT systems, resulting in the superior depiction of small anatomical structures and subtle lesions, which is valuable when detecting early-stage cancers, cardiovascular abnormalities, and neurological disorders. The use of photon counting CT is likely to become more prevalent in clinical practice because of its ability to provide sharper and more defined images compared to conventional systems, thereby improving patient care, patient outcomes, and clinical confidence.
Increased research and clinical validation to boost market growth
Various large medical imaging device manufacturers like Siemens Healthineers, GE HealthCare, and Canon Medical Systems among others are realizing the transformative potential of the technology and hence actively investing in or developing PCCT systems. For instance, in 2021, Siemens Healthineers launched and received FDA approval for its Naeotom Alpha, world’s first commercially approved PCCT system, thus setting a benchmark and opening the market. In 2024, Canon Medical Systems Corporation and Canon Healthcare USA, Inc. entered into a research collaboration with Penn Medicine for speeding the development of PCCT. In 2020, GE Healthcare acquired Prismatic Sensors, a Swedish start-up company having expertise in photon counting detectors, to strengthen their position in this market. The increased participation by both established and new imaging companies is a major contributor to the growth of the PCCT market, as it is driving innovation, increasing accessibility and moving photon counting CT from a research innovation to a mainstream diagnostic modality.
Competitive Landscape Analysis
The global photon counting CT market is marked by the presence of established and emerging market players such as Siemens Healthineers AG; GE Healthcare; Canon Medical Systems Corporation; Koninklijke Philips N.V.; Shanghai United Imaging Healthcare Co., LTD; Samsung; and Hitachi; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Get PDF Report for Competitive Analysis:
https://meditechinsights.com/photon-counting-computed-tomography-market/request-sample/
Global Photon Counting Computed Tomography (CT) Market Segmentation
This report by Medi-Tech Insights provides the size of the global photon counting CT market at the regional- and country-level from 2023 to 2030. The report further segments the market based on type, application, and end user.
Market Size & Forecast (2023-2030), By Technology, USD Million
- Single Detector PCCT
- Dual-Detector PCCT
- Multidetector PCCT
Market Size & Forecast (2023-2030), By Application, USD Million
- Oncology
- Cardiology
- Neurology
- Pulmonology
- Others
Market Size & Forecast (2023-2030), By End User, USD Million
- Hospitals
- Diagnostic Imaging Centers
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
